Abstract:OBJECTIVE:To detect the expression of S100A6 in gastric cancer, and to investigate the regulation mechanism of S100A6 in invasion and metastasis of gastric cancer.METHODS:Expression of S100A6 protein in gastric cancer specimens, tissue adjacent to cancer, liver and lymph node metastasis tissue specimens was detected by immunohistochemical staining in 166 patients with gastric cancer from January 1995 to December 2001. Their association with clinicopathological factors was analyzed. Chromatin Immunoprecipitation-chip was used to detect the downstream factors potentially regulated by S100A6 in gastric cancer cell lines KATO3. S100A6 gene was transfected into gastric cancer cell line AGS, and cell invasion experiment and real time Q-polymerase chain reaction(RT Q-PCR) were used to detect the cell invasive ability and the mRNA expression of invasion-related factors (CDK5 and FLJ12438) in transfection group, negative control group and blank control group, respectively.RESULTS:Low expression of S100A6 protein was found in cytoplasm of peritumoral tissues. In gastric cancer, liver and lymph node metastasis tissues, S100A6 protein expression was up-regulated in cytoplasm and (or) nuclei, especially in the tumor cells of invasive edge. The expression rates of gastric cancer, liver and lymph node metastasis tissues were 67.5%(112/166), 92.9%(26/28) and 100% (30/30) respectively. The high expression of S100A6 was associated with tumor local invasion, lymph node metastasis, cancer embolus, distant metastasis and TNM stages(all P<0.05). The transmembrane cell number was 31.3±5.5 in the S100A6 transfection group, significantly higher than that in negative control group (7.7±1.5) and blank control group (9.3±2.1)(both P<0.05), indicating an increase of cell invasion after S100A6 transfection. In transfection group, CDK5 mRNA expression was significantly higher than that in negative control group and blank control group(P<0.05). While FLJ1243 mRNA expression was similar among the three groups(P<0.05).CONCLUSION:S100A6 may affect the malignant biological behavior of gastric cancer cells by regulating the expressions of down-stream invasion-associated factors, such as CDK5.

Increased Expression of S100A6 Promotes Cell Proliferation and Migration in Human Hepatocellular Carcinoma

S100A6 Promotes Proliferation and Migration of HepG2 Cells Via Increased Ubiquitin-Dependent Degradation of P53.

S100A6 Promotes Proliferation of Intrahepatic Cholangiocarcinoma Cells Via the Activation of the P38/mapk Pathway.

Increased Expression of S100a6 Promotes Cell Proliferation in Gastric Cancer Cells

Hnf6 Promotes Tumor Growth In Colorectal Cancer And Enhances Liver Metastasis In Mouse Model

Involvement of S100A6/S100A11 in T-Cell Immune Regulatory in HCC Revealed by Single Cell RNA-seq

Interaction Of S100a1 With Lats1 Promotes Cell Growth Through Regulation Of The Hippo Pathway In Hepatocellular Carcinoma

S100 Calcium Binding Protein A10, A Novel Oncogene, Promotes the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma.

Clinical Significance and Biological Function of Co-Stimulation Molecule B7 Homolog 6 Expression in Human Hepatocellular Carcinoma

S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway

S100a6 Overexpression is Associated with Poor Prognosis and is Epigenetically Up-Regulated in Gastric Cancer

Comprehensive Analysis of the Prognosis and Correlations with Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma

S100A6 Promotes Cell Proliferation in Human Nasopharyngeal Carcinoma Via the P38/mapk Signaling Pathway

α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway.

[Regulation Mechanism Study of S100A6 on Invasion and Metastasis in Gastric Cancer].

Transcriptional activation of S100A2 expression by HIF-1α via binding to the hypomethylated hypoxia response elements in HCC cells

Prognostic Value of S100 Family Mrna Expression in Hepatocellular Carcinoma

Up-regulation of S100A4 Expression by HBx Protein Promotes Proliferation of Hepatocellular Carcinoma Cells and Its Correlation with Clinical Survival.

Influence of S100A6 gene overexpression on malignant phenotype of lung adenocarcinoma cell

S100A4 Promotes Hepatocellular Carcinogenesis by Intensifying Fibrosis-Associated Cancer Cell Stemness

High Expression of S 100 A 12 on Intratumoral Stroma Cells Indicates Poor Prognosis Following Surgical Resection of Hepatocellular Carcinoma